Since Bcl-2 was the target of AKT signaling pathway, we checked the change of AKT activity and found that Derlin-1 positively modulate AKT phosphorylation in bladder cancer cells (Figure 4A). This evidence concerns the gene DERL1 and urinary bladder carcinoma.